Vivesto AB (OTCPK:OASMY)
$ 0.0499 0 (0%) Market Cap: 8.95 Mil Enterprise Value: 3.84 Mil PE Ratio: 0 PB Ratio: 0.87 GF Score: 39/100

Full Year 2020 Oasmia Pharmaceutical AB Earnings Call Transcript

Feb 19, 2021 / 09:00AM GMT
Release Date Price: $1.1
Operator

Welcome to the Oasmia Pharmaceutical Q4 report. With us today, we have CEO, Francois Martelet; acting CFO, Robert Maiorana. (Operator Instructions)

I'll now hand over to Francois. Please go ahead.

Francois R. Martelet;publ;CEO
Oasmia Pharmaceutical AB

()-

Thank you very much, and good morning, everyone. Pleasure to be here with you today to provide an update on our Q3 and year-end results.

So just would like to say that from January 1 of this year, Oasmia will change the use of the calendar year as its financial year. So to make it -- this happen, this presentation does include an abbreviated financial year covering the period from May 1 until December 31, 2020, that means 8 months. And the comparative figures for the previous year reports the same period in -- of last year, which means 2019. So I think it's important for you to understand that.

All right. So moving to Slide 2. This is the forward-looking statements.

And on Slide 3. So -- as you heard -- so today, I will be joined by Robert.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot